Research Probes Soy - Prostate Cancer LinkJuly 30, 2002Researchers at the University of Ulster and Belfast City Hospital are set to launch a groundbreaking study that could offer a new insight into the prevention of prostate cancer. The study will focus on a significant link between low levels of serious prostate cancer and the presence of soy products in the diet. Professor Ian Rowland, from the University of Ulster said: "The incidence and mortality rate of certain cancers such as colorectal and prostate cancers, is much higher in Western countries than in the East. "It is thought that this may be due to the differences in the foods people eat in different parts of the world. Studies suggest that it is the high amounts of soy food that people eat in Eastern countries, such as Japan and China, that helps protect them against prostate cancer . "People in Western countries, like here in Northern Ireland, do not eat much soy at all-so we could be missing out on a protective effect. "This link between high soy consumption and low prostate cancer mortality is backed up by studies using animal fed high soy diets and by laboratory research using prostate cancer cells treated with compounds extracted from soy beans. Now what we need is evidence that soy can help to prevent the onset of prostate cancer, or, slow its progression, in humans. This is the primary aim of the new research project." The study will be carried out in collaboration with Dr Patrick Keane at Belfast City Hospital. Men attending the hospital for a biopsy of the prostate, will be invited to take part. Participants will be given milk drinks containing soy compounds over a four month period. Biological markers that indicate prostate cancer risk will then be measured to see whether the soy-rich diet had any beneficial effects. Any changes in the prostate cells themselves can also be detected. Professor Rowland highlighted the worrying number of cases of prostate cancer in the province and stressed the importance of the new study: "Statistics from the Northern Ireland Cancer Registry show that at least 470 new cases of prostate cancer are reported each year in Northern Ireland, and that prostate cancer causes around 200 deaths here per year. "It is the second most common cause of cancer death in males in Northern Ireland, and is catching up with lung cancer. Both incidence and mortality are increasing. That is why investigating new ways to prevent, or minimise the effects of the disease is so crucial." | |||||||||||||||||||||
|
Related Prostate Cancer News Articles Too much calcium in blood may increase risk of fatal prostate cancer Men who have too much calcium in their bloodstreams may have an increased risk of fatal prostate cancer, according to a new analysis from Wake Forest University School of Medicine and the University of Wisconsin. Height linked to risk of prostate cancer development and progression A man's height is a modest marker for risk of prostate cancer development, but is more strongly linked to progression of the cancer, say British researchers who conducted their own study on the connection and also reviewed 58 published studies. Health risk behaviors associated with lower prostate specific antigen awareness According to a study conducted at Columbia University Mailman School of Public Health, health risk behaviors such as smoking and obesity are associated with lower awareness of the Prostate Specific Antigen (PSA), which could lead to a lower likelihood of undergoing actual prostate cancer screening. Study shows PDE5 inhibitor more effective when used on demand in erectile dysfunction European Urology, the official journal of the European Association of Urology will be featuring the article 'Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy' by F. Montorsi et al.in the October issue, showing for the first time that vardenafil, a PDE5 inhibitor, is more efficacious when used on-demand in men with erectile dysfunction, supporting a shift towards on-demand dosing with PDE5 inhibitors in this patient group. Satisfaction and regret after radical prostatectomy procedures studied Studies have shown that approximately 16% of patients with localised prostate cancer regret their treatment choice. European Urology, the official journal of the European Association of Urology, will be publishing an article by J.W. Moul et al. comparing differences in satisfaction and regret between patients who underwent open retropubic radical prostatectomy and robot-assisted laparoscopic radical prostatectomy. State's first single incision robotic kidney removal For the first time in Michigan, a diseased kidney has been surgically removed at Henry Ford Hospital using highly sophisticated 3D robotics through a single incision. Anti-tumor effects are enhanced by inhibiting 2 pathways rather than 1 Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of these studies and highlights some of the questions that still need to be answered. Why a common treatment for prostate cancer ultimately fails Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences. PSA screening may be biased against obese men, leading to more aggressive cancers Testing men for elevated levels of prostate-specific antigen (PSA) in the blood -- the gold standard screening test for prostate cancer -- may be biased against obese men, whose PSA levels tend to be deceptively low. Study finds more PSA screening awareness needed among high-risk groups In one of the first examinations of PSA screening in younger men, a study published by researchers at Duke Medicine's Prostate Center finds that one-fifth of men under age 50 reported undergoing a prostate specific antigen (PSA) test to detect prostate cancer in the previous year, yet only one in three young black men reported ever having a PSA test in the previous year. More Prostate Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||